SCHEMBL15565330

SCHEMBL15565330

CC[C@H]1CC[C@@H](Oc2cccc3cc(CN4CCC(C(=O)O)CC4)ccc23)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 12/20 1.00
S1PR5 Q9H228 7/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15565015 1.00 ENPP2 (1.00) ENPP2S1PR5
SCHEMBL15565017 1.00 ENPP2 (1.00) ENPP2S1PR5
SCHEMBL15565122 0.91 ENPP2 (1.00) ENPP2S1PR5
SCHEMBL15565120 0.91 ENPP2 (1.00) ENPP2S1PR5
SCHEMBL15564750 0.91 ENPP2 (0.83) ENPP2S1PR5
SCHEMBL15564373 0.91 ENPP2 (0.83) ENPP2S1PR5
SCHEMBL15565705 0.91 ENPP2 (0.83) ENPP2S1PR5
SCHEMBL15565371 0.90 ENPP2 (1.00) ENPP2S1PR5
SCHEMBL19620324 0.90 ENPP2 (1.00) ENPP2S1PR5
SCHEMBL15565408 0.90 ENPP2 (1.00) ENPP2S1PR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10273234-B2 Compounds that are S1P modulating agents and/or ATX modulating agents BIOGEN MA INC. (US) 2019-04-30 US claimed
EP-2879674-B1 COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS BIOGEN MA INC (US) 2017-11-22 EP claimed
US-20150203493-A1 COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS BIOGEN IDEC MA INC. (US) 2015-07-23 US claimed
EP-2879674-A1 COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS Biogen MA Inc. (US) 2015-06-10 EP claimed
WO-2014025708-A1 COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS BIOGEN IDEC MA INC. (US) 2014-02-13 WO claimed
US-10273234-B2 Compounds that are S1P modulating agents and/or ATX modulating agents BIOGEN MA INC. (US) 2019-04-30 US disclosed
US-10273234-B2 Compounds that are S1P modulating agents and/or ATX modulating agents BIOGEN MA INC. (US) 2019-04-30 US disclosed
EP-2879674-B1 COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS BIOGEN MA INC (US) 2017-11-22 EP disclosed
EP-2879674-B1 COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS BIOGEN MA INC (US) 2017-11-22 EP disclosed
US-20150203493-A1 COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS BIOGEN IDEC MA INC. (US) 2015-07-23 US disclosed
US-20150203493-A1 COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS BIOGEN IDEC MA INC. (US) 2015-07-23 US disclosed
US-20150203493-A1 COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS BIOGEN IDEC MA INC. (US) 2015-07-23 US disclosed
EP-2879674-A1 COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS Biogen MA Inc. (US) 2015-06-10 EP disclosed
WO-2014025708-A1 COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS BIOGEN IDEC MA INC. (US) 2014-02-13 WO disclosed
WO-2014025708-A1 COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS BIOGEN IDEC MA INC. (US) 2014-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10273234-B2 Compounds that are S1P modulating agents and/or ATX modulating agents ENPP2, S1PR1, S1PR2 ENPP2 1/4885S1PR5 4/4885
US-20150203493-A1 COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS ENPP2, S1PR1, S1PR2 ENPP2 1/4885S1PR5 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.